SCHEMBL841789

SCHEMBL841789

OCCc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3960568 0.98
Hydrochloric Acid SCHEMBL3939821 0.98
Phosphoric Acid SCHEMBL6547515 0.90 FDPS (0.56)
SCHEMBL735969 0.86
SCHEMBL8671012 0.85 FDPS (0.47)
SCHEMBL2089915 0.85 FDPS (0.42)
SCHEMBL9256794 0.83 FDPS (0.41)
SCHEMBL7275156 0.83 FDPS (0.41)
SCHEMBL167744 0.80
SCHEMBL8381065 0.80 COPS5 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116286623-A Metabolic markers for screening young and senescent mesenchymal stem cell-derived exosomes and screening method 中国医学科学院基础医学研究所 2023-06-23 CN claimed
CN-105348215-B A kind of thiazole compound with beans Flavor odor characteristic and preparation method thereof 波顿(上海)生物技术有限公司 2018-01-02 CN claimed
CN-106433973-A Preparation method of perfume composition 东莞市联洲知识产权运营管理有限公司 2017-02-22 CN claimed
CN-102584740-B Synthesis method for 4-methyl-5-(2-ethoxyl)-thiazole TENGZHOU WUTONG PERFUME CO LTD 2013-11-27 CN claimed
WO-2013085954-A1 SUBSTITUTED PIPERIDINYL-CARBOXAMIDE DERIVATIVES USEFUL AS SCD 1 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2013-06-13 WO claimed
CN-102584740-A Synthesis method for 4-methyl-5-(2-ethoxyl)-thiazole TENGZHOU WUTONG PERFUME CO LTD 2012-07-18 CN claimed
US-8143408-B2 N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain ASTRAZENECA AB (SE) 2012-03-27 US claimed
US-20100137322-A1 NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2010-06-03 US claimed
US-20100056494-A1 PURINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FOR THE TREATMENT OF PLASMODIUM RELATED DISEASES IRM LLC (BM) 2010-03-04 US claimed
EP-2158198-A2 NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN AstraZeneca AB (SE) 2010-03-03 EP claimed
WO-2008094737-A2 PURINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FOR THE TREATMENT OF PLASMODIUM RELATED DISEASES IRM LLC (BM) 2008-08-07 WO claimed
EP-1746888-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES Viropharma Incorporated (US) 2007-01-31 EP claimed
CN-1271188-C Perfume compositions ZHOU JINGLONG (CN) 2006-08-23 CN claimed
WO-2005112640-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES VIROPHARMA INCORPORATED (US) 2005-12-01 WO claimed
CN-1544594-A Perfume compositions 周静龙 2004-11-10 CN claimed
EP-1054865-A1 FARNESYL TRANSFERASE INHIBITORS AstraZeneca UK Limited (GB) 2000-11-29 EP claimed
CN-1051546-C Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents ASTRA AB (SE) 2000-04-19 CN claimed
WO-1999041235-A1 FARNESYL TRANSFERASE INHIBITORS ASTRAZENECA UK LIMITED (GB) 1999-08-19 WO claimed
CN-1150426-A Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents ASTRA AB (SE) 1997-05-21 CN claimed
EP-0516069-A1 Leukotriene B4 antagonist SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1992-12-02 EP claimed